Center for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Hôpital Général Yaoundé, Yaoundé, Cameroon.
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):359-367. doi: 10.1158/1055-9965.EPI-19-0506. Epub 2019 Dec 23.
Sub-Saharan Africa (SSA) has a high proportion of premenopausal hormone receptor negative breast cancer. Previous studies reported a strikingly high prevalence of germline mutations in and among Nigerian patients with breast cancer. It is unknown if this exists in other SSA countries.
Breast cancer cases, unselected for age at diagnosis and family history, were recruited from tertiary hospitals in Kampala, Uganda and Yaoundé, Cameroon. Controls were women without breast cancer recruited from the same hospitals and age-matched to cases. A multigene sequencing panel was used to test for germline mutations.
There were 196 cases and 185 controls with a mean age of 46.2 and 46.6 years for cases and controls, respectively. Among cases, 15.8% carried a pathogenic or likely pathogenic mutation in a breast cancer susceptibility gene: 5.6% in , 5.6% in , 1.5% in , 1% in , 0.5% in , 0.5% in , and 0.5% in . Among controls, 1.6% carried a mutation in one of these genes. Cases were 11-fold more likely to carry a mutation compared with controls (OR = 11.34; 95% confidence interval, 3.44-59.06; < 0.001). The mean age of cases with mutations was 38.3 years compared with 46.7 years among other cases without such mutations ( = 0.03).
Our findings replicate the earlier report of a high proportion of mutations in among patients with symptomatic breast cancer in SSA.
Given the high burden of inherited breast cancer in SSA countries, genetic risk assessment could be integrated into national cancer control plans.
撒哈拉以南非洲(SSA)有很大比例的绝经前激素受体阴性乳腺癌。先前的研究报告称,尼日利亚乳腺癌患者中 和 种系突变的发生率极高。目前尚不清楚这种情况是否存在于其他 SSA 国家。
从乌干达坎帕拉和喀麦隆雅温得的三级医院招募未按诊断时年龄和家族史选择的乳腺癌病例和未患乳腺癌的对照。对照组从同一医院招募,与病例年龄匹配。使用多基因测序面板检测种系突变。
共纳入 196 例病例和 185 例对照,病例和对照的平均年龄分别为 46.2 岁和 46.6 岁。在病例中,15.8%携带乳腺癌易感性基因中的致病性或可能致病性突变:5.6%在 ,5.6%在 ,1.5%在 ,1%在 ,0.5%在 ,0.5%在 ,0.5%在 。对照中,有 1.6%携带这些基因中的一个突变。病例携带突变的可能性是对照的 11 倍(OR = 11.34;95%置信区间,3.44-59.06; < 0.001)。携带 突变的病例的平均年龄为 38.3 岁,而其他无此类突变的病例的平均年龄为 46.7 岁( = 0.03)。
我们的研究结果复制了早期关于 SSA 有症状乳腺癌患者中 突变比例高的报告。
鉴于 SSA 国家遗传性乳腺癌的负担沉重,遗传风险评估可以纳入国家癌症控制计划。